Skip to content
BAX·NYSE·US

Baxter

Baxter, through its subsidiaries, provides a broad portfolio of essential healthcare products, including sterile IV solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. These products are used by hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. As of December 31, 2025, the company manufactured products in over 20 countries and sold them in over 100 countries.

Source: SEC 10-K Feb 12, 2026

Thematic Position

Relationship Groups

Suppliers3
Customers1
Partners1
Licensing1
Competitors1

Relationship details are part of the Pro plan.

Ended Relationships

1 ended relationship · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade policy
US tariff policy changes and IEEPA invalidation affect Baxter's costs and refund claims
SEC 10-QApr 30, 2026

The full regulatory passage is part of the Pro plan.

18 more · Regulatory and geopolitical insights are part of the Pro plan.